STOCK TITAN

Phreesia Form 144 Discloses 93-Share Sale; Recent Insider Sales Listed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) filed a Form 144 reporting a proposed sale of 93 common shares through Fidelity Brokerage Services with an aggregate market value of $2,226.29, slated for 09/18/2025. The filing shows those 93 shares were acquired by restricted stock vesting on 09/15/2025 (35 shares) and 09/16/2025 (58 shares) and were received as compensation. The issuer has 59,914,473 shares outstanding, so the proposed sale represents a de minimis fraction of the outstanding stock. The filing also lists multiple insider sales over the past three months, including larger transactions by David Linetsky (e.g., 23,729 shares on 06/27/2025 for $676,195.48). The notice includes the standard signer representations about absence of undisclosed material information.

Positive

  • Clear disclosure of acquisition dates, nature of acquisition (restricted stock vesting), broker, and proposed sale details
  • Proposed sale size is de minimis relative to total shares outstanding (93 shares vs. 59,914,473 outstanding)
  • Past sales are itemized, providing transparency about recent insider transactions including dates and gross proceeds

Negative

  • Insider selling activity in the past three months includes larger disposals (e.g., 23,729 shares on 06/27/2025 for $676,195.48), which may warrant investor attention
  • No statement of a 10b5-1 trading plan date is provided in the remarks, so it is unclear whether the sales are pre-planned

Insights

TL;DR: Small proposed sale (93 shares, $2,226) from recently vested restricted stock; not material to capitalization but follows notable insider selling this year.

The Form 144 reports a routine sale of vested restricted shares that were acquired as compensation on 09/15/2025 and 09/16/2025. At 93 shares and $2,226 aggregate value against 59.9 million shares outstanding, this notice is immaterial to Phreesia's market capitalization. However, the filing should be read alongside disclosed insider disposals in the prior three months, notably a 23,729-share sale on 06/27/2025, which indicates ongoing insider liquidity events that investors may want to contextualize with trading plans and federal exemptions.

TL;DR: Filing appears procedurally correct and includes signer representation; ensure timing aligns with Rule 144 requirements and any 10b5-1 plans.

The Form 144 furnishes acquisition dates, nature of acquisition (restricted stock vesting), broker details, and recent sale history, matching disclosure expectations. The filer attests to no undisclosed material information. From a compliance perspective, the close proximity of vesting and proposed sale dates is permissible but should be verified against any company blackout periods or pre-existing Rule 10b5-1 arrangements. No explicit plan dates are included in the remarks.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Phreesia's Form 144 (PHR) report for the proposed sale?

The filing reports a proposed sale of 93 common shares via Fidelity with aggregate market value $2,226.29, approximately to be sold on 09/18/2025.

How were the 93 shares acquired according to the Form 144?

The 93 shares were acquired by restricted stock vesting: 35 shares on 09/15/2025 and 58 shares on 09/16/2025, and the nature of payment is listed as compensation.

How large is the proposed sale relative to Phreesia's outstanding shares?

Phreesia has 59,914,473 shares outstanding; the proposed 93-share sale is a de minimis portion of the outstanding equity.

Does the filing show other insider sales recently?

Yes. The filing lists multiple insider sales in the past three months, including 23,729 shares sold by David Linetsky on 06/27/2025 for $676,195.48.

Who is the broker named in the proposed sale?

The broker listed is Fidelity Brokerage Services LLC at the Smithfield, RI address.
Phreesia

NYSE:PHR

PHR Rankings

PHR Latest News

PHR Latest SEC Filings

PHR Stock Data

991.72M
57.12M
4.19%
99.86%
4.91%
Health Information Services
Services-business Services, Nec
Link
United States
WILMINGTON